CRE enters the week with an unusual combination: a stock priced well below its estimated intrinsic value, a borrow market so loose it barely registers, and a recent earnings history that has consistently surprised to the upside — yet the shares remain roughly 3% lower on the month at 451p.
The lending market tells the least threatening short story in the reinsurance sector right now. Availability is essentially unlimited — the 9,999% reading reflects a pool of 17.4 million shares available to borrow against negligible actual demand, and utilisation has been drifting lower all month, from around 0.84% in early June to just 0.45% today. Cost to borrow has eased alongside it, pulling back to 0.55% after a brief spike toward 0.84% earlier in the month. The ORTEX short score of 28.3, which ranks in the 81st percentile for low short positioning, reinforces the picture: this stock is not a short target.
The valuation angle is more interesting. CRE trades at just 0.74x book value — a multiple that has slipped about 3.5% over the past month — and at a trailing P/E of 6.8x. The DPS/Price ratio of nearly 6% reflects the dividend paid in March (£0.134 per share), which remains the only distribution since mid-2022 in the recent record. The price/book discount is notable for a profitable reinsurer; it suggests the market is either pricing in continued margin pressure or simply overlooking the stock. The analyst mean price target of £7.21 implies roughly 60% upside from current levels — though that figure is now about three weeks old and no recent analyst changes are on record, so it should be treated as directional rather than precise.
The earnings track record supports the bull case more than the current price suggests. The most recent set of results, released in May, drove a 4.5% one-day gain and an 8.1% five-day follow-through. The February results were even stronger — a 10.2% one-day move and a 15.2% gain over five days. Two consecutive positive post-earnings reactions of that magnitude are not common in the sector, and they suggest management has been consistently delivering above market expectations. The EPS surprise factor score of 60 and the 12-month forward EPS growth rank of 77 both point in the same direction.
Ownership is concentrated and largely stable. Fidelity International holds 10.6% and has not changed its position since May. Víctor Vallejo, the second-largest holder at 9.9%, last reported in December. The one notable flow is Lancaster Investment Management, which trimmed by around 1.1 million shares as of mid-May, reducing its stake to 3.5%. That is the only confirmed directional move among the top holders in recent months. Insider activity in the 90 days to March consisted mainly of equity awards to CEO Neil Eckert and CFO Elaine Whelan at zero cost, alongside a small matched buy-and-sell from an independent director — nothing that changes the read on management conviction.
Among peers, SPNT led the reinsurance cohort this week with a 6% gain, while MUV2 and SCR both added around 3-4%. CRE's 2.6% weekly gain kept pace with the broader group, though its month is still in the red while most peers are flat to positive. The key data point to track from here is whether the price/book discount narrows on the back of any fresh analyst commentary or a trading update — the gap between where the shares trade and where book value and consensus targets sit is the central tension in this name.
See the live data behind this article on ORTEX.
Open CRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
